BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30882319)

  • 1. Mucosal Leishmaniasis in Travelers with Leishmania braziliensis Complex Returning to Israel.
    Solomon M; Sahar N; Pavlotzky F; Barzilai A; Jaffe CL; Nasereddin A; Schwartz E
    Emerg Infect Dis; 2019 Apr; 25(4):642-648. PubMed ID: 30882319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imported mucosal leishmaniasis in a traveler.
    Scope A; Trau H; Bakon M; Yarom N; Nasereddin A; Schwartz E
    Clin Infect Dis; 2003 Sep; 37(6):e83-7. PubMed ID: 12955668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous leishmaniasis with secondary mucosal disease in a traveller due to Leishmania (Viannia) braziliensis.
    Crone CG; Helleberg M
    J Travel Med; 2020 Feb; 27(1):. PubMed ID: 31776570
    [No Abstract]   [Full Text] [Related]  

  • 4. First case of cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis in Suriname.
    Hu RV; Kent AD; Adams ER; van der Veer C; Sabajo LO; Mans DR; de Vries HJ; Schallig HD; Lai A Fat RF
    Am J Trop Med Hyg; 2012 May; 86(5):825-7. PubMed ID: 22556081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmaniasis in Bolivia. II. The involvement of Psychodopygus yucumensis and Psychodopygus llanosmartinsi in the selvatic transmission cycle of Leishmania braziliensis braziliensis in a lowland subandean region.
    Le Pont F; Desjeux P
    Mem Inst Oswaldo Cruz; 1986; 81(3):311-8. PubMed ID: 3574129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon.
    Guerra JA; Prestes SR; Silveira H; Coelho LI; Gama P; Moura A; Amato V; Barbosa Md; Ferreira LC
    PLoS Negl Trop Dis; 2011 Mar; 5(3):e980. PubMed ID: 21408116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parasitological diagnosis of mucocutaneous leishmaniasis due to Leishmania b. braziliensis in Bolivia.
    Dimier-David L; David C; Ravisse P; Bustillos R; Revollo S; Lyèvre P; Muñoz M; Vargas F; Dedet JP
    Rev Soc Bras Med Trop; 1991; 24(4):231-4. PubMed ID: 1845007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
    Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
    Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers.
    Solomon M; Pavlotzky F; Barzilai A; Schwartz E
    J Am Acad Dermatol; 2013 Feb; 68(2):284-9. PubMed ID: 22858005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical complexity of Leishmania (Viannia) braziliensis infections amongst travelers.
    Eichner S; Thoma-Uszynski S; Herrgott I; Sebald H; Debus A; Tsianakas A; Ehrchen J; Harms G; Simon M; Sunderkötter C; Bogdan C
    Eur J Dermatol; 2013 Apr; 23(2):218-23. PubMed ID: 23557633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-Infection of Leishmania (Viannia) braziliensis and HIV: report of a case of mucosal leishmaniasis in Cochabamba, Bolivia.
    Torrico F; Parrado R; Castro R; Marquez CJ; Torrico MC; Solano M; Reithinger R; García AL
    Am J Trop Med Hyg; 2009 Oct; 81(4):555-8. PubMed ID: 19815865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemoculture of Leishmania (Viannia) braziliensis from two cases of mucosal leishmaniasis: re-examination of haematogenous dissemination.
    Martinez JE; Alba ; Arias L; Escobar MA; Saravia NG
    Trans R Soc Trop Med Hyg; 1992; 86(4):392-4. PubMed ID: 1440813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the Endobiont Double-Stranded RNA Virus LRV1 With Treatment Failure for Human Leishmaniasis Caused by Leishmania braziliensis in Peru and Bolivia.
    Adaui V; Lye LF; Akopyants NS; Zimic M; Llanos-Cuentas A; Garcia L; Maes I; De Doncker S; Dobson DE; Arevalo J; Dujardin JC; Beverley SM
    J Infect Dis; 2016 Jan; 213(1):112-21. PubMed ID: 26123565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New world mucosal and cutaneous leishmaniasis: an emerging health problem among British travellers.
    Lawn SD; Whetham J; Chiodini PL; Kanagalingam J; Watson J; Behrens RH; Lockwood DN
    QJM; 2004 Dec; 97(12):781-8. PubMed ID: 15569809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysis.
    Boggild AK; Caumes E; Grobusch MP; Schwartz E; Hynes NA; Libman M; Connor BA; Chakrabarti S; Parola P; Keystone JS; Nash T; Showler AJ; Schunk M; Asgeirsson H; Hamer DH; Kain KC;
    J Travel Med; 2019 Dec; 26(8):. PubMed ID: 31553455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal leishmaniasis due to Leishmania (Viannia) braziliensis L(V)b in Três Braços, Bahia-Brazil.
    Marsden PD
    Rev Soc Bras Med Trop; 1994; 27(2):93-101. PubMed ID: 8073158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tegumentary leishmaniasis by Leishmania braziliensis complex in Cochabamba, Bolivia including the presence of L. braziliensis outlier: Tegumentary leishmaniasis in Cochabamba, Bolivia: Tegumentary leishmaniasis in Cochabamba, Bolivia.
    Torrico MC; Fernández-Arévalo A; Ballart C; Solano M; Rojas E; Ariza E; Tebar S; Lozano D; Abras A; Gascón J; Picado A; Muñoz C; Torrico F; Gállego M
    Transbound Emerg Dis; 2022 Jul; 69(4):2242-2255. PubMed ID: 34232559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis.
    Solomon M; Baum S; Barzilai A; Scope A; Trau H; Schwartz E
    J Am Acad Dermatol; 2007 Apr; 56(4):612-6. PubMed ID: 17276541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Gene Expression and Infection Profiles of Cutaneous and Mucosal Leishmania braziliensis Isolates from the Same Patient.
    Alves-Ferreira EV; Toledo JS; De Oliveira AH; Ferreira TR; Ruy PC; Pinzan CF; Santos RF; Boaventura V; Rojo D; López-Gonzálvez Á; Rosa JC; Barbas C; Barral-Netto M; Barral A; Cruz AK
    PLoS Negl Trop Dis; 2015; 9(9):e0004018. PubMed ID: 26366580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of parasite DNA in clinically unaffected nasal mucosa during cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.
    Canário A; Queiroz M; Cunha G; Cavalcante T; Riesz V; Sharma R; de Noronha A; Correia T; Barral-Netto M; Barral A; Khouri R; Boaventura V
    Clin Microbiol Infect; 2019 Apr; 25(4):515.e5-515.e7. PubMed ID: 30616010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.